Literature DB >> 17084815

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Tetsuaki Arai1, Masato Hasegawa, Haruhiko Akiyama, Kenji Ikeda, Takashi Nonaka, Hiroshi Mori, David Mann, Kuniaki Tsuchiya, Mari Yoshida, Yoshio Hashizume, Tatsuro Oda.   

Abstract

Ubiquitin-positive tau-negative neuronal cytoplasmic inclusions and dystrophic neurites are common pathological features in frontotemporal lobar degeneration (FTLD) with or without symptoms of motor neuron disease and in amyotrophic lateral sclerosis (ALS). Using biochemical and immunohistochemical analyses, we have identified a TAR DNA-binding protein of 43 kDa (TDP-43), a nuclear factor that functions in regulating transcription and alternative splicing, as a component of these structures in FTLD. Furthermore, skein-like inclusions, neuronal intranuclear inclusions, and glial inclusions in the spinal cord of ALS patients are also positive for TDP-43. Dephosphorylation treatment of the sarkosyl insoluble fraction has shown that abnormal phosphorylation takes place in accumulated TDP-43. The common occurrence of intracellular accumulations of TDP-43 supports the hypothesis that these disorders represent a clinicopathological entity of a single disease, and suggests that they can be newly classified as a proteinopathy of TDP-43.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084815     DOI: 10.1016/j.bbrc.2006.10.093

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  937 in total

1.  Neurotoxic effects of TDP-43 overexpression in C. elegans.

Authors:  Peter E A Ash; Yong-Jie Zhang; Christine M Roberts; Tassa Saldi; Harald Hutter; Emanuele Buratti; Leonard Petrucelli; Christopher D Link
Journal:  Hum Mol Genet       Date:  2010-06-08       Impact factor: 6.150

Review 2.  TDP-43 aggregation in neurodegeneration: are stress granules the key?

Authors:  Colleen M Dewey; Basar Cenik; Chantelle F Sephton; Brett A Johnson; Joachim Herz; Gang Yu
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

3.  Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; Amanda M Serie; Ralph B Perkerson; Billie J Matchett; Clifford R Jack; David S Knopman; Ronald C Petersen; Joseph E Parisi; Leonard Petrucelli; Matthew Baker; Rosa Rademakers; Jennifer L Whitwell; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2019-01-02       Impact factor: 17.088

4.  VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death.

Authors:  Michael A Gitcho; Jeffrey Strider; Deborah Carter; Lisa Taylor-Reinwald; Mark S Forman; Alison M Goate; Nigel J Cairns
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

5.  FUS regulates genes coding for RNA-binding proteins in neurons by binding to their highly conserved introns.

Authors:  Tadashi Nakaya; Panagiotis Alexiou; Manolis Maragkakis; Alexandra Chang; Zissimos Mourelatos
Journal:  RNA       Date:  2013-02-06       Impact factor: 4.942

Review 6.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

Review 7.  Profilin1 biology and its mutation, actin(g) in disease.

Authors:  Duah Alkam; Ezra Z Feldman; Awantika Singh; Mahmoud Kiaei
Journal:  Cell Mol Life Sci       Date:  2016-09-26       Impact factor: 9.261

8.  Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.

Authors:  Nigel J Cairns; Eileen H Bigio; Ian R A Mackenzie; Manuela Neumann; Virginia M-Y Lee; Kimmo J Hatanpaa; Charles L White; Julie A Schneider; Lea Tenenholz Grinberg; Glenda Halliday; Charles Duyckaerts; James S Lowe; Ida E Holm; Markus Tolnay; Koichi Okamoto; Hideaki Yokoo; Shigeo Murayama; John Woulfe; David G Munoz; Dennis W Dickson; Paul G Ince; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2007-06-20       Impact factor: 17.088

9.  Differential roles of GluN2A- and GluN2B-containing NMDA receptors in neuronal survival and death.

Authors:  Brendan Lujan; Xiaoxuan Liu; Qi Wan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

10.  Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis.

Authors:  Yoshitaka Tashiro; Makoto Urushitani; Haruhisa Inoue; Masato Koike; Yasuo Uchiyama; Masaaki Komatsu; Keiji Tanaka; Maya Yamazaki; Manabu Abe; Hidemi Misawa; Kenji Sakimura; Hidefumi Ito; Ryosuke Takahashi
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.